Taofeek Kunle Owonikoko
机构：University of Maryland, Baltimore, U-M Rogel Cancer Center, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Baltimore · ORCID：0000-0002-7724-7728
发表论文 708 篇 · 总被引 59612 次 · h-index 89
代表论文
- Tarlatamab in Small-Cell Lung Cancer after Platinum-Based Chemotherapy (2025 · New England Journal of Medicine · 被引 270)
- Practical management of adverse events in patients receiving tarlatamab, a delta‐like ligand 3–targeted bispecific T‐cell engager immunotherapy, for previously treated small cell lung cancer (2025 · Cancer · 被引 48)
- Chemoradiation ± Atezolizumab in Limited-Stage Small Cell Lung Cancer: Results of NRG Oncology/Alliance LU005 (2026 · Journal of Clinical Oncology · 被引 19)
- DeLLphi-301: Tarlatamab phase 2 trial in small cell lung cancer (SCLC)—Efficacy and safety analyzed by presence of brain metastasis. (2024 · Journal of Clinical Oncology · 被引 18)
- IDeate-Lung02: A phase 3, randomized, open-label study of ifinatamab deruxtecan (I-DXd) vs treatment of physician’s choice (TPC) in relapsed small cell lung cancer (SCLC). (2024 · Journal of Clinical Oncology · 被引 14)
- IDeate-Lung02: a Phase 3 study of second-line ifinatamab deruxtecan in patients with relapsed small cell lung cancer (2025 · Future Oncology · 被引 12)